Literature DB >> 15206967

Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases.

M Khurrum Baig1, H Marquez, J J Nogueras, E G Weiss, S D Wexner.   

Abstract

INTRODUCTION: Pyoderma gangrenosum is a rare idiopathic skin disorder associated with other diseases, including inflammatory bowel disease. The commonest site is the skin, but sometimes it can occur in the parastomal region. Most of these cases respond to treatment with systemic corticosteroids and cyclosporin or local Kenalog injections.
METHODS: The following are two cases of parastomal pyoderma in patients not responding to the standard measures. These patients were treated with topical tacrolimus.
RESULTS: These patients showed dramatic improvement in one week with complete resolution and re-epithelialization of skin within two weeks.
CONCLUSION: Pyoderma gangrenosum is a difficult problem to manage and its early resolution is important. In these two reported cases, the improvement was dramatic, therefore topical tacrolimus should be considered early in the management.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15206967     DOI: 10.1111/j.1463-1318.2004.00607.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  4 in total

Review 1.  Pyoderma gangrenosum: pathogenetic oriented treatment approaches.

Authors:  Uwe Wollina; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2014-06-05

Review 2.  Pyoderma gangrenosum--a review.

Authors:  Uwe Wollina
Journal:  Orphanet J Rare Dis       Date:  2007-04-15       Impact factor: 4.123

3.  Pyoderma gangrenosum with monoclonal IgA gammopathy and pulmonary tuberculosis. Illustrative case and review.

Authors:  Krystyna Romańska-Gocka; Czanita Cieścińska; Barbara Zegarska; Robert A Schwartz; Jakub Cieściński; Dorota Olszewska-Słonina; Rafał Czajkowski
Journal:  Postepy Dermatol Alergol       Date:  2015-03-30       Impact factor: 1.837

4.  Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease.

Authors:  Shantini A Rice; Pick N Woo; Emad El-Omar; Ronald A Keenan; Anthony D Ormerod
Journal:  BMC Res Notes       Date:  2013-01-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.